Form SEC STAFF LETTER - SEC Staff Letter: REDACTED EXHIBIT
SEC Accession No. 9999999997-23-004208
Filing Date
2023-09-19
Accepted
2023-09-19 16:58:40
Documents
1

Document Format Files

Seq Description Document Type Size
1 filename1.pdf REDACTED EXHIBIT 46700
  Complete submission text file 9999999997-23-004208.txt   65374
Mailing Address 345 PARK AVENUE SOUTH FLOOR 6 NEW YORK NY 10010
Business Address 345 PARK AVENUE SOUTH FLOOR 6 NEW YORK NY 10010 (212) 547-9879
Lexeo Therapeutics, Inc. (Filer) CIK: 0001907108 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SEC STAFF LETTER
SIC: 2836 Biological Products, (No Diagnostic Substances)